PRRG3
Transmembrane gamma-carboxyglutamic acid protein 3
Also known as: TMG3, TMG3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BZD7
- Gene
- PRRG3
- Ensembl
- ENSG00000130032
- Chromosome
- X
- Canonical length
- 231 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a protein which contains a vitamin K-dependent carboxylation/gamma-carboxyglutamic domain. The encoded protein is a member of a family of vitamin K-dependent transmembrane proteins which contain a glutamate-rich extracellular domain. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
231 residues, UniProt reviewed canonical sequence.
>Q9BZD7|PRRG3
1 MAVFLEAKDA HSVLKRFPRA NEFLEELRQG TIERECMEEI CSYEEVKEVF ENKEKTMEFW
61 KGYPNAVYSV RDPSQSSDAM YVVVPLLGVA LLIVIALFII WRCQLQKATR HHPSYAQNRY
121 LASRAGHTLP RVMVYRGTVH SQGEPSGHRE AANSPQVVLG PSRGGRTTVR LESTLYLPEL
181 SLSRLSSTTP PPSYEEVTAP QESSSEEASV SYSDPPPKYE EIVAANPGAD KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRRG3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 11 nTPM
- basal ganglia: 9.7 nTPM
- cerebral cortex: 9.7 nTPM
- epididymis: 7 nTPM
- hippocampal formation: 5.2 nTPM
- amygdala: 5.1 nTPM
Single-cell type
- other brain neurons: 18 nCPM
- brain inhibitory neurons: 14 nCPM
- brain excitatory neurons: 13 nCPM
- medullary thymic epithelial cells: 12 nCPM
- fibro-adipogenic progenitors: 8.7 nCPM
- fibroblasts: 8.5 nCPM
Immune cell
- basophil: 1.2 nTPM
- neutrophil: 0.7 nTPM
- NK-cell: 0.5 nTPM
- non-classical monocyte: 0.4 nTPM
- eosinophil: 0.3 nTPM
- MAIT T-cell: 0.3 nTPM
Brain region
- cerebral cortex: 34 nTPM
- basal ganglia: 34 nTPM
- hypothalamus: 31 nTPM
- white matter: 29 nTPM
- pons: 23 nTPM
- hippocampal formation: 22 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.76
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRRG3 as an antibody target. Whether an autoantibody or antibody against PRRG3 could matter depends on whether native PRRG3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRRG3 is annotated as secreted, so native PRRG3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PRRG3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...